HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suliat I Abdulai Selected Research

COVID-19

10/2022Phylogenic analysis of coronavirus genome and molecular studies on potential anti-COVID-19 agents from selected FDA-approved drugs.
1/2022Molecular basis for the repurposing of histamine H2-receptor antagonist to treat COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Suliat I Abdulai Research Topics

Disease

2COVID-19
10/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

1Coronavirus Nucleocapsid ProteinsIBA
10/2022
1Anti-Bacterial Agents (Antibiotics)IBA
10/2022
1Antimalarials (Antimalarial Agents)IBA
10/2022
1hemagglutinin esteraseIBA
10/2022
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
10/2022
1LopinavirFDA Link
10/2022
1Levofloxacin (Levaquin)FDA Link
10/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1Cimetidine (Biomet)FDA LinkGeneric
01/2022
1Histamine (Histamine Dihydrochloride)FDA Link
01/2022
1Famotidine (Pepcid)FDA LinkGeneric
01/2022